Xarelto in the Prophylaxis of Post Surgical Venous Thromboembolism After Elective Major Orthopedic Surgery of Hip or Knee in Indian Patients

Trial Profile

Xarelto in the Prophylaxis of Post Surgical Venous Thromboembolism After Elective Major Orthopedic Surgery of Hip or Knee in Indian Patients

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 11 Feb 2016

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
  • Focus Adverse reactions
  • Acronyms XYRIS
  • Sponsors Bayer
  • Most Recent Events

    • 03 Feb 2016 Status changed from suspended to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
    • 15 Jun 2015 Planned End Date changed from 1 Nov 2014 to 1 Nov 2016, according to ClinicalTrials.gov record.
    • 15 Jun 2015 Planned primary completion date changed from 1 Nov 2014 to 1 Nov 2016, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top